Ethical issues in direct-to-consumer healthcare: A scoping review
PLOS Digital Health · 13.02.2024 · 3 (2) · e0000452
DOI: 10.1371/journal.pdig.0000452 ↗Kurz gefasst
Scoping Review in der Zeitschrift PLOS Digital Health, online erschienen am 13.02.2024. Verfasst von Ashwini Nagappan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, University of California, Los Angeles, Los Angeles, California, United States of America. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, AHRQ HHS.
Abstract (Originalsprache)
An increasing number of health products and services are being offered on a direct-to-consumer (DTC) basis. To date, however, scholarship on DTC healthcare products and services has largely proceeded in a domain-specific fashion, with discussions of relevant ethical challenges occurring within specific medical specialties. The present study therefore aimed to provide a scoping review of ethical issues raised in the academic literature across types of DTC healthcare products and services. A systematic search for relevant publications between 2011–2021 was conducted on PubMed and Google Scholar using iteratively developed search terms. The final sample included 86 publications that discussed ethical issues related to DTC healthcare products and services. All publications were coded for ethical issues mentioned, primary DTC product or service discussed, type of study, year of publication, and geographical context. We found that the types of DTC healthcare products and services mentioned in our sample spanned six categories: neurotechnology (34%), testing (20%), in-person services (17%), digital health tools (14%), telemedicine (13%), and physical interventions (2%). Ethical arguments in favor of DTC healthcare included improved access (e.g., financial, geographical; 31%), increased autonomy (29%), and enhanced convenience (16%). Commonly raised ethical concerns included insufficient regulation (72%), questionable efficacy and quality (70%), safety and physical harms (66%), misleading advertising claims (56%), and privacy (34%). Other frequently occurring ethical concerns pertained to financial costs, targeting vulnerable groups, informed consent, and potential burdens on healthcare providers, the healthcare system, and society. Our findings offer insights into the cross-cutting ethical issues associated with DTC healthcare and underscore the need for increased interdisciplinary communication to address the challenges they raise.
Autor:innen und Institutionen
- Department of Health Policy and Management, University of California, Los Angeles, Los Angeles, California, United States of America.
- Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, United States of America.
ORCID-Profile: Ashwini Nagappan, Louiza Kalokairinou, Anna Wexler
Förderung
- NIH HHS
- NIA NIH HHS
- AHRQ HHS
- NCATS NIH HHS
- NIH Office of the Director
- National Institute on Aging
Zitieren
APA
Nagappan, A., Kalokairinou, L., & Wexler, A. (2024). Ethical issues in direct-to-consumer healthcare: A scoping review. PLOS Digital Health, 3(2), e0000452. https://doi.org/10.1371/journal.pdig.0000452
Vancouver
Nagappan A, Kalokairinou L, Wexler A. Ethical issues in direct-to-consumer healthcare: A scoping review. PLOS Digital Health. 2024;3(2):e0000452. doi:10.1371/journal.pdig.0000452
BibTeX
@article{Nagappan2024,
author = {Nagappan, Ashwini and Kalokairinou, Louiza and Wexler, Anna},
title = {Ethical issues in direct-to-consumer healthcare: A scoping review},
journal = {PLOS Digital Health},
year = {2024},
volume = {3},
number = {2},
pages = {e0000452},
doi = {10.1371/journal.pdig.0000452}
}
EUVIMED